Want to see TELA full AI Analyst Report?
TELA Bio (TELA) Ratios
TELA Bio Ratios
TELA's free cash flow for Q2 2026 was $-9.44M. For the 2026 fiscal year, TELA's free cash flow was decreased by $-59.00K and operating cash flow was $-9.38M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.20 | 5.01 | 4.23 | 5.03 | 5.58 |
| Quick Ratio | 3.59 | 4.19 | 3.45 | 4.08 | 4.86 |
| Cash Ratio | 2.83 | 3.38 | 2.75 | 3.39 | 4.15 |
| Solvency Ratio | -0.50 | -0.63 | -0.78 | -0.81 | -0.77 |
| Operating Cash Flow Ratio | -1.57 | -2.67 | -2.41 | -3.29 | -2.88 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -76.32 | -72.31 | -119.85 | 0.00 |
| Net Current Asset Value | $ 476.00K | $ 19.20M | $ 12.56M | $ 8.90M | $ 16.61M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.68 | 0.49 | 0.55 | 0.61 | 0.50 |
| Debt-to-Equity Ratio | 8.82 | 1.51 | 2.26 | 2.90 | 1.57 |
| Debt-to-Capital Ratio | 0.90 | 0.60 | 0.69 | 0.74 | 0.61 |
| Long-Term Debt-to-Capital Ratio | 0.90 | 0.59 | 0.68 | 0.74 | 0.61 |
| Financial Leverage Ratio | 12.90 | 3.07 | 4.13 | 4.74 | 3.11 |
| Debt Service Coverage Ratio | -6.21 | -5.41 | -7.02 | -8.90 | -8.10 |
| Interest Coverage Ratio | -6.44 | -6.45 | -8.44 | -9.63 | -8.19 |
| Debt to Market Cap | 1.00 | 0.48 | 0.27 | 0.22 | 0.17 |
| Interest Debt Per Share | 1.30 | 1.69 | 2.10 | 2.80 | 2.42 |
| Net Debt to EBITDA | -0.15 | 0.30 | 0.10 | 0.01 | 0.43 |
| Profitability Margins | |||||
| Gross Profit Margin | 67.69% | 67.08% | 68.62% | 65.30% | 63.85% |
| EBIT Margin | -41.55% | -47.18% | -70.90% | -97.17% | -100.73% |
| EBITDA Margin | -40.29% | -45.72% | -69.51% | -94.30% | -98.92% |
| Operating Profit Margin | -42.05% | -49.23% | -75.40% | -94.18% | -99.96% |
| Pretax Profit Margin | -48.09% | -54.81% | -79.83% | -106.95% | -112.94% |
| Net Profit Margin | -48.37% | -54.60% | -79.83% | -106.95% | -112.94% |
| Continuous Operations Profit Margin | -48.37% | -54.60% | -79.83% | -106.95% | -112.94% |
| Net Income Per EBT | 100.60% | 99.62% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 114.36% | 111.34% | 105.87% | 113.56% | 112.99% |
| Return on Assets (ROA) | -47.69% | -43.33% | -59.79% | -65.28% | -53.20% |
| Return on Equity (ROE) | -615.10% | -132.97% | -247.15% | -309.65% | -165.57% |
| Return on Capital Employed (ROCE) | -53.21% | -47.56% | -72.16% | -70.34% | -56.67% |
| Return on Invested Capital (ROIC) | -53.21% | -47.02% | -71.50% | -69.92% | -56.67% |
| Return on Tangible Assets | -48.50% | -44.21% | -61.46% | -67.78% | -55.24% |
| Earnings Yield | -70.09% | -43.92% | -30.82% | -23.68% | -17.96% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.76 | 6.86 | 6.00 | 6.26 | 6.96 |
| Payables Turnover | 11.23 | 10.63 | 11.00 | 9.37 | 4.41 |
| Inventory Turnover | 2.35 | 1.78 | 1.39 | 1.22 | 1.39 |
| Fixed Asset Turnover | 21.53 | 16.99 | 14.84 | 14.24 | 24.84 |
| Asset Turnover | 0.99 | 0.79 | 0.75 | 0.61 | 0.47 |
| Working Capital Turnover Ratio | 1.34 | 1.18 | 1.12 | 0.84 | 0.47 |
| Cash Conversion Cycle | 169.59 | 223.33 | 289.56 | 318.83 | 232.18 |
| Days of Sales Outstanding | 47.05 | 53.19 | 60.80 | 58.35 | 52.45 |
| Days of Inventory Outstanding | 155.04 | 204.50 | 261.93 | 299.44 | 262.46 |
| Days of Payables Outstanding | 32.50 | 34.35 | 33.17 | 38.95 | 82.73 |
| Operating Cycle | 202.09 | 257.69 | 322.73 | 357.78 | 314.91 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.60 | -1.46 | -1.79 | -2.50 | -2.10 |
| Free Cash Flow Per Share | -0.61 | -1.49 | -1.81 | -2.62 | -2.15 |
| Dividend Paid and CapEx Coverage Ratio | -62.99 | -42.06 | -66.87 | -21.77 | -48.54 |
| Capital Expenditure Coverage Ratio | -62.99 | -42.06 | -66.87 | -21.77 | -48.54 |
| Operating Cash Flow Coverage Ratio | -0.51 | -0.97 | -0.96 | -0.98 | -0.97 |
| Operating Cash Flow to Sales Ratio | -0.35 | -0.60 | -0.70 | -0.98 | -1.03 |
| Free Cash Flow Yield | -51.75% | -49.43% | -27.39% | -22.78% | -16.77% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.42 | -2.27 | -3.24 | -4.22 | -5.57 |
| Price-to-Sales (P/S) Ratio | 0.69 | 1.24 | 2.59 | 4.52 | 6.29 |
| Price-to-Book (P/B) Ratio | 8.78 | 3.03 | 8.02 | 13.08 | 9.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.93 | -2.02 | -3.65 | -4.39 | -5.96 |
| Price-to-Operating Cash Flow Ratio | -1.96 | -2.07 | -3.71 | -4.59 | -6.09 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | 0.07 | 0.13 | -0.23 | -1.77 |
| Enterprise Value Multiple | -1.86 | -2.42 | -3.63 | -4.78 | -5.93 |
| Enterprise Value | 60.21M | 76.54M | 147.43M | 186.52M | 172.82M |
| EV to EBITDA | -1.86 | -2.42 | -3.63 | -4.78 | -5.93 |
| EV to Sales | 0.75 | 1.10 | 2.52 | 4.50 | 5.87 |
| EV to Free Cash Flow | -2.10 | -1.80 | -3.56 | -4.38 | -5.56 |
| EV to Operating Cash Flow | -2.13 | -1.84 | -3.61 | -4.58 | -5.68 |
| Tangible Book Value Per Share | 0.11 | 0.94 | 0.73 | 0.73 | 1.23 |
| Shareholders’ Equity Per Share | 0.13 | 1.00 | 0.83 | 0.88 | 1.39 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.71 | 2.43 | 2.56 | 2.55 | 2.04 |
| Net Income Per Share | -0.83 | -1.33 | -2.04 | -2.72 | -2.30 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.16 | 1.16 | 1.13 | 1.10 | 1.12 |
| Research & Development to Revenue | 0.11 | 0.13 | 0.16 | 0.22 | 0.23 |
| SG&A to Revenue | 0.98 | 1.15 | 0.25 | 0.33 | 0.42 |
| Stock-Based Compensation to Revenue | 0.05 | 0.06 | 0.09 | 0.10 | 0.12 |
| Income Quality | 0.73 | 1.10 | 0.88 | 0.92 | 0.91 |
Currency in USD
